Twitter Beğeni Hilesi

🆕 #ProjectNextGen opportunity under the RRPV | Rapid Response Partnership Vehicle. Interested in supporting the development of manufacturing technologies that can produce on demand vaccines & therapeutics against #COVID19 & other #HealthSecurity threats? Submit abstracts by 9/25: ow.ly/Iv7650T18iV

There’s still time to submit! DRIVe is seeking proposals to advance metagenomic next generation sequencing as a diagnostic tool against viral pathogens. Submit by September 30, 2024: ow.ly/wekV50RRHxL

To ensure communities are protected against infectious diseases, we’re partnering to advance vaccine delivery methods, enhance vaccine storage capability, support vaccine research & development for safe, effective, accessible vaccines. Learn more: ow.ly/xs3A50T28M2

For #NIAM, we’re highlighting opportunities to partner with us on vaccine innovation. Through #ProjectNextGen & our DRIVe program, we’ve launched the Patch Forward prize, a competition to incentivize patch-based vaccine technology innovation: ow.ly/ua5r50T2hWK

Have an innovative technology and looking for partnership opportunities? Check out our new Partnering Page to find out more about BARDA funding opportunities: ow.ly/Uc5s50T1x77

🆕 #ProjectNextGen opportunity under the RRPV | Rapid Response Partnership Vehicle. Interested in supporting the development of manufacturing technologies that can produce on demand vaccines & therapeutics against #COVID19 & other #HealthSecurity threats? Submit abstracts by 9/25: ow.ly/Iv7650T18iV

We’re procuring doses of OPVEE, an U.S. FDA-approved emergency opioid overdose treatment from Indivior, to treat people during mass casualty incidents. Learn more: ow.ly/ETVT50T4mx5

BARDA DRIVe is accepting proposals for the Digital Medical Countermeasures (MCM) program! We’re looking for innovative computational approaches, including AI, that could become digital MCMs for health security threats. Learn more & contact the team at: ow.ly/JAnv50RSZEE

We're working w/ partners to develop alternative methods of vaccine administration like pills & nasal sprays. These vaccines can stimulate localized immune responses at the site of infection, elicit more diverse antibody responses, & avoid needles: ow.ly/7QjK50T2ip1 #NIAM

We’re continuing the celebrations of the 4th anniversary of BLUE KNIGHT™. Rachel Rath & Ashim Subedee reflect on the collaboration and share their excitement for what’s to come. jji.jnj/3T4jftH

We’re hosting a meeting w/ @NIAIDnews & NIDAnews: “Advances in Developing Medical Countermeasures Against Opioids & Drug-Induced Respiratory Depression.” Join us Dec. 17-18 in Rockville, MD. Space is limited, so register today: ow.ly/1yp750T8UrC #ioad2024

We're seeking #medicalcountermeasures to treat life-threatening respiratory depression caused by drug overdose during mass casualty incidents. Treatments should be fast acting & effective against a variety of opioids including fentanyl. For more: ow.ly/ajyj50T8IIG #ioad2024

There's still time to submit your proposal to the Strategic Partnership Solicitation for D-COHRe! DRIVe is seeking partnerships to enhance clinical research innovation with decentralized care capabilities & to enhance preparedness. Submit by 12/9/24: ow.ly/7F9c50Stb2i